These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21206608)

  • 1. Risperidone induced tardive dyskinesia - a case report.
    Vasudevan OV; Pinto DA; Gopinath PS
    Indian J Psychiatry; 2002 Oct; 44(4):384-6. PubMed ID: 21206608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone implicated in the onset of tardive dyskinesia in a young woman.
    Kumar S; Malone DM
    Postgrad Med J; 2000 May; 76(895):316-7. PubMed ID: 10775299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive Dyskinesia Following Low-Dose Risperidone.
    Rokon AE; Alsomali FA; Alrasheed MA; Alharbi AD; Alhamadh MS; Alqahtani AM; Alhamidy FK; Alotaibi MR
    Cureus; 2022 Dec; 14(12):e32319. PubMed ID: 36628029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone Abruption-Induced Tardive Dyskinesia in a Six-Year-Old Male Patient With Known Autism and Attention Deficit Hyperactivity Disorder: A Case Report.
    Alhamoud AH; Yatimi A; Towheri SA; Sharahili HA; Hawas AM
    Cureus; 2022 Nov; 14(11):e31492. PubMed ID: 36408307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
    Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS
    J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
    Nelson MW; Reynolds RR; Kelly DL; Conley RR
    Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study.
    Bai YM; Yu SC; Chen JY; Lin CY; Chou P; Lin CC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):79-85. PubMed ID: 15729082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report.
    Haile K; Umer H
    SAGE Open Med Case Rep; 2019; 7():2050313X19833254. PubMed ID: 30834119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone and olanzapine induced tardive dyskinesia : a critical review of reported cases.
    Singh GP
    Indian J Psychiatry; 2004 Oct; 46(4):319-23. PubMed ID: 21206790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: treatment with aripiprazole.
    Kang NR; Kim MD
    Clin Psychopharmacol Neurosci; 2011 Apr; 9(1):1-8. PubMed ID: 23430384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia on low dose risperidone.
    Alugo T; Kelly F; O'Grady-Walsh A; Whitty P
    Ir J Psychol Med; 2010 Mar; 27(1):45-46. PubMed ID: 30282295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dystonia provoked by concomitantly administered risperidone.
    Tachikawa H; Suzuki T; Kawanishi Y; Hori M; Hori T; Shiraishi H
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):503-5. PubMed ID: 10997870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.